Welcome to our dedicated page for HERBALIFE LTD. SEC filings (Ticker: HLF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Herbalife Ltd. filings document the regulatory record of a Cayman Islands health and wellness company with common shares listed on the New York Stock Exchange under HLF. Form 8-K reports cover quarterly and annual financial results, Regulation FD materials, material definitive agreements, senior secured notes due 2033, and amendments to secured credit facilities involving company subsidiaries.
Proxy materials cover annual general meeting procedures, shareholder voting matters, and governance. The filings also describe capital-structure subjects, security registration details, and formal disclosures related to the company’s products, network marketing program, and legal or regulatory risk areas.
Mulligan Donal L reported acquisition or exercise transactions in this Form 4 filing.
Herbalife Ltd. director Donal L. Mulligan reported an equity award. He received 11,879 shares of Common Stock in the form of restricted stock units granted under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan at no cash cost.
The RSUs will vest 100% on April 15, 2027, if he continues to serve on the Board through that date. After this grant, he directly holds 68,982 shares of Common Stock and also has an indirect holding of 60,000 shares held by a trust.
L'Helias Sophie reported acquisition or exercise transactions in this Form 4 filing.
HERBALIFE LTD. director Sophie L’Helias reported receiving an equity award of 11,879 shares of Common Stock in the form of restricted stock units (RSUs) at no cash cost. These RSUs were granted under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan.
The RSUs will vest 100% on April 15, 2027, if she continues serving on the Board of Directors through that date. After this grant, she reports beneficial ownership of 78,682 shares of Common Stock, reflecting her total direct position as of this filing.
Miller Perkins reported acquisition or exercise transactions in this Form 4 filing.
Herbalife Ltd. director Miller Perkins reported receiving 13,626 shares of Common Stock in the form of restricted stock units (RSUs). These RSUs were granted under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan and carry a grant price of $0.00 per share.
The RSUs will vest 100% on April 15, 2027, provided Perkins continues to serve on the company’s Board of Directors through that date. After this grant, Perkins directly holds 50,769 shares of Herbalife common stock.
HERBALIFE LTD. director Des Walsh filed an initial Form 3 to report his beneficial ownership of the company’s common stock. The filing shows indirect ownership of 200,000 shares held "By Trust" and direct ownership of 50,000 shares. This Form 3 records existing holdings rather than new open‑market purchases or sales.
HERBALIFE LTD. president Robert Levy filed an amended Form 3 to correct his reported holdings of common stock. The amendment shows he directly holds 154,145 shares of common stock, including 142,740 shares of deferred common stock that were inadvertently omitted from his original Form 3 and a Form 4 filed on May 5, 2026. This filing updates disclosure of ownership rather than reporting a new stock transaction.
HLF: Notice of proposed resale of 134,982 shares of Common Stock. The filing lists 134,982 shares classified as Restricted Stock Vesting available for sale by the holder, with a listed aggregate value of $1,822,211.46.
The filing also shows 7,937 shares sold in the past three months (trade date 05/11/2026) with proceeds of $110,002.00. Shares outstanding are shown as 103,669,416 as of 05/12/2026.
HERBALIFE LTD. filed a Form 144 notice regarding proposed sales of Common Stock. The filing lists two entries: a Restricted Stock Lapse on 05/03/2026 for 5,981 shares and a Restricted Stock Lapse on 05/04/2026 for 1,956 shares. The excerpt also shows a share-count line of 103,669,416 with a date of 05/11/2026.
Herbalife Ltd. reported solid first-quarter 2026 growth, with net sales of $1,317.2 million, up 7.8% year-over-year and 5.4% in constant currency, and adjusted EBITDA of $175.7 million, above guidance. Net income attributable to Herbalife was $61.9 million, and diluted EPS was $0.57, or $0.64 on an adjusted basis.
The company refinanced $1.45 billion of senior secured debt, using proceeds, revolver borrowings and cash to repay a $365 million term loan and fully redeem $800 million of 12.250% senior secured notes, which is expected to yield about $45 million in annual cash interest savings. Herbalife also acquired substantially all assets of Bioniq’s core personalized nutrition business for $55 million in base consideration plus up to $95 million in contingent payments, expanding its personalized nutrition offerings.
Shareholders elected eleven directors, approved executive compensation on an advisory basis, and ratified PricewaterhouseCoopers LLP as independent auditor. Management raised the midpoints of full-year 2026 constant currency net sales and adjusted EBITDA guidance, now targeting net sales growth of 1.0% to 5.0% and adjusted EBITDA of $675 million to $705 million.
Herbalife Ltd. reported stronger results for the three months ended March 31, 2026. Net sales reached $1,317.2 million, up from $1,221.7 million a year earlier, while net income attributable to Herbalife rose to $61.9 million from $50.4 million.
Basic earnings per share were $0.60 versus $0.50, and diluted earnings per share were $0.57 versus $0.49. Operating cash flow improved sharply to $113.8 million from $0.2 million, helping lift cash and cash equivalents to $451.2 million. Total assets were $2,875.2 million against total liabilities of $3,309.4 million, leaving a shareholders’ deficit of $434.2 million, though this deficit narrowed year over year.
Debt remained high, with long-term debt of $1,981.9 million and total interest expense of $49.5 million, slightly lower than the prior year. India and Mexico delivered notable sales contributions, and the company booked $5.5 million of government grant income in China, reported as other operating income.
HERBALIFE LTD reports 5,448,134.21 shares beneficially owned (5.3%) by FMR LLC as of 03/31/2026, per Schedule 13G. The filing states FMR LLC has sole dispositive power for 5,448,134.21 shares and sole voting power of 5,427,344.40. It also notes other persons may have dividend rights but no other person holds more than 5%.